Samphire Neuroscience
For decades we have treated hormones, when we should have been treating the brain.
$2.3M Pre Seed ·
Source: fundraisingfox.com
Latest round on record: Seed, June 2025, amount undisclosed.
All 3 rounds ↓Signals
About Samphire Neuroscience
Samphire builds advanced brain based technologies to tackle pain and mood symptoms caused by hormonal change.
Samphire Neuroscience | 820 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com | |
| Pre Seed | $2.3M | — | fundraisingfox.com |
Timeline
Founders and team
ER
Emilė Radytė CEO (Founder)source: samphireneuro.comAC
Alex Cook COO (Founder)source: samphireneuro.com
Investors
Companies like Samphire Neuroscience
DDYNAMICS VRSeed · Mar 2026
UUnfabledSeed · Oct 2025
CCardiac Dimensions$53M Series B+ · Mar 2025
CCoMind
NNeurocarrus
PPrima MenteSeed · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/samphire-neuroscience (get a free API key).